These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 15907526)

  • 61. Argatroban for anticoagulation in continuous renal replacement therapy.
    Link A; Girndt M; Selejan S; Mathes A; Böhm M; Rensing H
    Crit Care Med; 2009 Jan; 37(1):105-10. PubMed ID: 19050602
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Intraoperative management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].
    Ohno H; Yokoi M
    Masui; 2002 Jan; 51(1):30-3. PubMed ID: 11840659
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
    Hellwig TR; Peitz GJ; Gulseth MP
    Am J Health Syst Pharm; 2012 Mar; 69(6):490-5. PubMed ID: 22382479
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actions.
    Escolar G; Bozzo J; Maragall S
    Drugs Today (Barc); 2006 Apr; 42(4):223-36. PubMed ID: 16703119
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Concomitant use of argatroban and warfarin during hemodialysis in heparin-induced thrombocytopenia.
    Vianello F; Furian L; Nordio M; Treleani M; Fabris F
    Hematology; 2015 Jan; 20(1):48-9. PubMed ID: 24580134
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices.
    Samuels LE; Kohout J; Casanova-Ghosh E; Hagan K; Garwood P; Ferdinand F; Goldman SM
    Ann Thorac Surg; 2008 May; 85(5):1651-5. PubMed ID: 18442558
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia.
    Keegan SP; Gallagher EM; Ernst NE; Young EJ; Mueller EW
    Ann Pharmacother; 2009 Jan; 43(1):19-27. PubMed ID: 19116377
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
    Lewis BE; Walenga JM; Wallis DE
    Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial.
    Tardy-Poncet B; Nguyen P; Thiranos JC; Morange PE; Biron-Andréani C; Gruel Y; Morel J; Wynckel A; Grunebaum L; Villacorta-Torres J; Grosjean S; de Maistre E
    Crit Care; 2015 Nov; 19():396. PubMed ID: 26556106
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
    Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M
    Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use.
    Lubenow N; Selleng S; Wollert HG; Eichler P; Müllejans B; Greinacher A
    Ann Thorac Surg; 2003 Feb; 75(2):577-9. PubMed ID: 12607680
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Hursting MJ; Levine RL; Leya F
    Chest; 2006 Jun; 129(6):1407-16. PubMed ID: 16778256
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Anesthetic management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].
    Saito T; Uchida E; Saima S; Chiba A; Arai T; Okuda Y
    Masui; 2009 Sep; 58(9):1169-71. PubMed ID: 19764444
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Experimental and clinical results with the thrombin inhibitor Argatroban].
    Breddin HK
    Hamostaseologie; 2002 Aug; 22(3):55-9. PubMed ID: 12215762
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of renal function on the pharmacodynamics of argatroban.
    Arpino PA; Hallisey RK
    Ann Pharmacother; 2004 Jan; 38(1):25-9. PubMed ID: 14742788
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of heparin-induced thrombocytopenia: a practical argatroban dosing protocol for nurses.
    Cypher S
    J Infus Nurs; 2006; 29(6):318-25. PubMed ID: 17122687
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Use of argatroban as a substitute for heparin in a patient with suspected HIT type II undergoing carotid endarterectomy].
    Fujisawa M; Nakazawa K; Makita K
    Masui; 2004 Sep; 53(9):1057-60. PubMed ID: 15500112
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patients.
    Smythe MA; Koerber JM; Forsyth LL; Priziola JL; Balasubramaniam M; Mattson JC
    Pharmacotherapy; 2009 Sep; 29(9):1073-81. PubMed ID: 19698012
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of renal function on argatroban therapy during percutaneous coronary intervention.
    Hursting MJ; Jang IK
    J Thromb Thrombolysis; 2010 Jan; 29(1):1-7. PubMed ID: 19504050
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Argatroban therapy in heparin-induced thrombocytopenia.
    Sparks ML
    AACN Adv Crit Care; 2009; 20(1):37-43. PubMed ID: 19174636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.